Report

Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies

Science  19 Aug 2011:
Vol. 333, Issue 6045, pp. 1030-1034
DOI: 10.1126/science.1206954

Log in to view full text

Via your Institution

Log in through your institution

Log in through your institution


Related Content

Subjects

Navigate This Article